Hero Image

Early Signs of Acute Myeloid Leukemia (AML) Explained

If you’re looking for a clear guide to the early signs of Acute Myeloid Leukemia (AML), you’re in the right place.

Below, you’ll find what AML is, why certain symptoms appear, who’s most at risk, and practical steps for getting the right tests and care.

What Is Acute Myeloid Leukemia (AML)?

Acute Myeloid Leukemia is a fast-growing cancer of the blood and bone marrow—the spongy tissue where new blood cells form. In AML, immature myeloid cells (called “blasts”) multiply rapidly and crowd out healthy cells. That crowding leads to low counts of normal red blood cells, infection-fighting white blood cells, and platelets, which is why early AML symptoms often look like anemia, frequent infections, or unusual bleeding. For an in-depth overview, see the American Cancer Society and the National Cancer Institute.

The word “acute” means symptoms develop quickly and treatment should begin promptly. AML isn’t one single disease—subtypes are defined by genetic and chromosomal changes in the leukemia cells. These differences help guide treatment decisions and influence prognosis.

Early Signs and Symptoms to Watch For

Most early AML symptoms stem from a shortage of healthy blood cells; recognizing clusters of these clues—especially if they persist—warrants medical attention.

Below are the most common symptom groups and why they occur.

Symptoms Related to Low Red Blood Cells (Anemia)

  • Persistent fatigue and weakness: Feeling unusually tired or short on energy most days, not improved by rest.
  • Shortness of breath: Getting winded walking up stairs or doing routine activities.
  • Pale skin: Noticing a paler tone of the skin, lips, or inner eyelids.
  • Dizziness or lightheadedness: Especially on standing.

Symptoms Related to Low White Blood Cells (Neutropenia)

  • Frequent or hard-to-clear infections: Recurrent colds, sinus infections, or infections that don’t improve as expected.
  • Unexplained fevers: Fever without a clear source can be a sign of infection when white blood cells are low. Learn more about infection risks in people with cancer from the CDC.

Symptoms Related to Low Platelets (Thrombocytopenia)

  • Easy bruising: Bruises appear with little or no known injury.
  • Nosebleeds and bleeding gums: Bleeding that is frequent or hard to stop.
  • Petechiae: Tiny red or purple pinpoint spots on the skin, often on the legs or feet.
  • Prolonged bleeding from cuts: Small cuts bleed longer than usual.

Other Possible Signs

  • Bone or joint pain: A deep ache due to crowded bone marrow.
  • Swollen abdomen: Enlargement of the liver or spleen can cause a sense of fullness or swelling.
  • Loss of appetite or unintentional weight loss: General cancer-related symptoms.
  • Swollen or bleeding gums: Seen in certain AML subtypes when leukemia cells infiltrate gum tissue.
  • Skin lumps or greenish nodules (myeloid sarcoma/chloroma): Less common, but can occur when leukemia cells form masses outside the marrow.

Who Is at Higher Risk?

Most people with AML don’t have a clear cause, but several factors raise risk. Having risk factors doesn’t mean you’ll develop AML; it simply signals the need to be alert to symptoms and maintain regular checkups. For a detailed review, see the ACS overview of AML risk factors.

  • Age: AML is most common in adults over 65.
  • Previous chemotherapy or radiation: “Therapy-related” AML can develop years after treatment for another cancer.
  • Certain inherited syndromes: Conditions like Down syndrome and Fanconi anemia increase risk.
  • Exposure to chemicals such as benzene: Long-term, high-level exposure elevates risk; see NIOSH/CDC guidance.
  • Smoking: Tobacco smoke contains benzene and other carcinogens; resources to quit are available at Smokefree.gov.
  • Other blood disorders: Conditions like myelodysplastic syndromes (MDS) can evolve into AML.

When to Seek Medical Care (and What Tests to Expect)

If you notice several of the symptoms above—especially if they persist for more than a couple of weeks—schedule an appointment with your primary care clinician. Ask about a complete blood count (CBC), which checks red cells, white cells, and platelets. Abnormal results often prompt referral to a hematologist (a blood specialist).

To confirm AML and plan treatment, specialists may order:

  • Peripheral blood smear: A close look at blood cells under a microscope.
  • Bone marrow exam: A sample from the hip bone is examined to identify blasts and perform specialized tests; learn more about the procedure from the American Cancer Society.
  • Genetic and molecular testing: Tests for changes such as FLT3, NPM1, or IDH1/2 help determine risk and guide targeted therapy choices. See the NCI’s patient-friendly AML guide here.

One special subtype, acute promyelocytic leukemia (APL), requires immediate treatment because it can cause serious bleeding. The good news: APL is highly curable when treated promptly.

How AML Is Treated

Treatment usually starts quickly after diagnosis and is tailored to your age, overall health, and the leukemia’s genetic features. Broadly, therapy has two phases: remission induction (to clear leukemia cells from the blood and marrow) and consolidation (to prevent relapse).

  • Chemotherapy: Often the first-line approach to induce remission.
  • Targeted therapies: Some drugs home in on specific gene changes. Learn more about targeted options from the Leukemia & Lymphoma Society. Examples include midostaurin for FLT3-mutated AML and IDH inhibitors for IDH1/2-mutated AML; for some newly diagnosed adults who aren’t fit for intensive chemo, combinations with venetoclax are common.
  • Stem cell (bone marrow) transplant: In selected patients—especially those at higher risk of relapse—an allogeneic transplant can offer the best chance of cure. Read about transplants at the LLS.
  • Supportive care: Transfusions, antibiotics/antivirals, growth factors, and careful management of side effects. See a primer on transfusions from the American Cancer Society.

Your team will also discuss clinical trials, which can provide access to promising therapies. Talk with your hematologist about options recommended for your specific AML subtype.

Living With AML: Practical Tips

  • Call early for fevers: During treatment, a fever of 100.4°F (38°C) or higher can be an emergency—don’t wait; contact your team right away.
  • Prevent infections: Follow hand hygiene, avoid sick contacts when counts are low, and ask your team about food safety and mask use during high-risk periods.
  • Stay on top of vaccines: Some vaccines are recommended before or between treatments; see clinician guidance on immunization in immunocompromised patients from the CDC and follow your doctor’s plan.
  • Mind energy and nutrition: Small, frequent meals; manage nausea proactively; ask about seeing an oncology dietitian.
  • Ask about survivorship care: Plan for follow-up visits, blood tests, and monitoring to catch and treat any relapse early.

Outlook and Statistics

Outcomes vary depending on age, overall health, and AML genetics. Survival rates continue to improve thanks to better supportive care and targeted drugs. For up-to-date population statistics, visit SEER. Remember, statistics can’t predict any one person’s course—your care team can put your results in context.

Frequently Asked Questions

What’s the difference between acute and chronic leukemia?

Acute leukemias (like AML) involve immature cells and progress quickly, requiring prompt treatment. Chronic leukemias involve more mature-appearing cells and usually progress more slowly.

Is AML hereditary?

Most AML cases are not inherited. However, having a first-degree relative with AML slightly increases risk, and certain genetic syndromes raise the chance of developing AML. Genetic counseling may be useful if there’s a strong family history of blood cancers.

How is AML treated in broad strokes?

Care typically includes induction chemotherapy to achieve remission, followed by consolidation therapy to reduce relapse risk. Some people benefit from targeted therapies and/or a stem cell transplant. The NCI offers a comprehensive patient guide.

Is there a highly curable subtype?

Yes—acute promyelocytic leukemia (APL) is considered highly curable when treated immediately with specialized drugs (ATRA and arsenic trioxide). Because APL can cause serious bleeding, urgent evaluation is essential.

Next Steps

  • If symptoms persist, request a CBC and ask for a referral to a hematologist if results are abnormal.
  • Bring a list of your symptoms, medications, and prior treatments to your appointment.
  • Explore trusted resources: the American Cancer Society, NCI, LLS, and the NCCN AML Patient Guidelines.

Disclaimer: This guide is for educational purposes only and is not a substitute for professional medical advice. Always consult a qualified healthcare professional about any symptoms or treatment decisions.